Since naringin, in addition to exenatide, can inhibit the NF-κB signaling pathway and thus reverse SR stress, this natural constituent of BPF could be a valid substitute and/or support for the treatment of diabetic cardiomyopathy. The gene discussed is NFKB1; the disease is diabetic cardiomyopathy.